This reduction of disease-related components may affect the level of RA fatigue, and previous research has shown that both anti-tumor necrosis factor (anti-TNF) and non-anti-TNF biologics produce similar improvements in fatigue (Almeida et al., 2016). Here, TNF is linked to rheumatoid arthritis.